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Abstract
Comorbidity patterns have become a major source of information to explore shared mecha-
nisms of pathogenesis between disorders. In hypothesis-free exploration of comorbid condi-
tions, disease-disease networks are usually identified by pairwise methods. However,
interpretation of the results is hindered by several confounders. In particular a very large
number of pairwise associations can arise indirectly through other comorbidity associations
and they increase exponentially with the increasing breadth of the investigated diseases. To
investigate and filter this effect, we computed and compared pairwise approaches with a
systems-based method, which constructs a sparse Bayesian direct multimorbidity map
(BDMM) by systematically eliminating disease-mediated comorbidity relations. Additionally,
focusing on depression-related parts of the BDMM, we evaluated correspondence with
results from logistic regression, text-mining and molecular-level measures for comorbidities
such as genetic overlap and the interactome-based association score. We used a subset of
the UK Biobank Resource, a cross-sectional dataset including 247 diseases and 117,392
participants who filled out a detailed questionnaire about mental health. The sparse comor-
bidity map confirmed that depressed patients frequently suffer from both psychiatric and
somatic comorbid disorders. Notably, anxiety and obesity show strong and direct relation-
ships with depression. The BDMM identified further directly co-morbid somatic disorders,
e.g. irritable bowel syndrome, fibromyalgia, or migraine. Using the subnetwork of depression
and metabolic disorders for functional analysis, the interactome-based system-level score
showed the best agreement with the sparse disease network. This indicates that these epi-
demiologically strong disease-disease relations have improved correspondence with
expected molecular-level mechanisms. The substantially fewer number of comorbidity rela-
tions in the BDMM compared to pairwise methods implies that biologically meaningful
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Author summary
Depression is one of the most common of psychiatric disorders and its causation is corre-
spondingly multifactorial, complex and heterogeneous. It occurs in combination with a
number of physical illnesses far more commonly than expected by chance. Such comor-
bidities may be important clues pointing to shared environmental and genetic risk factors
and could identify different causal types of depression. However, a method is still needed
to weed out statistically significant pairings that nevertheless arise through indirect routes
involving comorbidities between other diseases. We examined the pairwise associations
among 247 diseases of 117,392 participants recorded in the UK Biobank database. We
found that the great majority of disease associations were indirect consequences of a
sparse network of ‘direct’ comorbidities (‘sparse diseaseome’) constructed using probabi-
listic graphical models (PGMs) within the Bayesian statistical framework. In a depression-
related subset of illnesses, we found that several pairwise associations of depression were
indirect and due to their comorbidities with obesity which had a strong direct connection
with depression. Furthermore, the direct comorbidities in a depression-related subset of
disorders, but not the pairwise associations, strongly mapped onto an underlying molecu-
lar network (‘interactome’) suggesting that this approach significantly improved corre-
spondence with molecular reality.
Introduction
It has long been recognised that medical disorders frequently co-occur in the same individual
[1] but the significance of comorbidity in revealing shared mechanisms of pathogenesis and
outcome is a more recent realisation [2–4]. For a given disease or for a focused disease group,
the exploration of comorbidities is largely hypothesis driven, together with the cautious selec-
tion and management of potential confounders [4–7]. The availablility of large health data sets
with full multimorbidity information provides an unprecedented opportunity to understand
the overall network of dependencies underpinning complex multimorbidities. These multivar-
iate dependencies in turn become new targets for drug development and other therapies for
multimorbid conditions, particularly relevant in aging societies [8–10]. However, the dissec-
tion of comorbidity relations is hindered by myriads of confounding factors [11–13]. Follow-
ing the characterization from Bagley et al. [12], epidemiological co-occurrences can arise
through different routes: 1) shared genetic background, 2) disease interactions (a disorder
directly causes another), 3) common environmental cause and 4) different biases (diagnosis
artifacts, selection biases). Earlier diseasome-wide works focused on the exploration of shared
genetic background (1) behind comorbidities [2, 3, 12, 13] and the underlying molecular net-
works [3, 14–18]. These works relied on pairwise comorbid relations partly controlled for
potential confounding factors such as age (for controlling with disease onset see e.g. [2], for
incidence-based control see e.g. [12]). However, these approaches do not address the issue of
apparent comorbidity mediated by intervening associations with other diseases; a problem of
indirect relations that is already attracting attention in other areas of network science [19].
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In this paper we demonstrate that probabilistic graphical models (PGMs) in the Bayesian
statistical framework provide a principled, unified solution for filtering such disease-mediated
indirect relations, for correcting for potential external confounders and for coping with limita-
tions and uncertainty of the data. Specifically, we construct sparse multimorbidity maps by
applying PGMs for all diseases, i.e. for the whole diseasome. To our knowledge, this method
has not been applied for the diseasome so far, despite the unique ability of PGMs to represent
maximally sparse models, demonstrated on, for example genomic datasets [19–25]. Our disea-
some-wide evaluations show that this approach efficiently scores and discriminates direct and
disease-mediated indirect comorbidity relations and has resulted in a loss of more than 80% of
comorbidity relations from prevailing pairwise methods.
We made a more detailed investigation of BDMMs in the subset of psychiatric and meta-
bolic disorders of the diseaseome. We focused on depression, which is a common psychiatric
disorder with a complex neurobiological and psychosocial background [26, 27], with approx-
imately 10% prevalence worldwide, and according to forecasts depression will be the largest
contributor to the disease burden in the middle- and high-income countries by 2030 accord-
ing to the World Health Organization [28–30]. Many epidemiologic studies have reported
high comorbidity between mental illnesses [5, 31], which was partly explained by shared her-
itability between psychiatric disorders [32, 33]. Less is known about the complex biopsycho-
social mechanisms which underlie associations between somatic and common psychiatric
disorders: depression frequently co-occurs with a wide range of somatic disorders, for exam-
ple with migraine [34], with other disorders causing chronic pain [35, 36], and with cardio-
metabolic syndromes [37]. It has been also demonstrated that patients with depression have
increased number of diagnosed disorders compared to non-depressed patients [5, 38] and
depression worsens the treatment outcome of the comorbid conditions [39] and is an inde-
pendent predictor of increased mortality rate [40, 41]. Therefore besides the exploration of
further comorbidities of depression, it is equally important to discriminate its comorbidities
as direct and indirect comorbidities. Such discrimination could reveal more specific patho-
physiological subgroups of this heterogeneous condition and thus transform the power of
genetic and epidemiological studies to advance precision medicine in psychiatry and meta-
bolic disorders.
We also evaluated the correspondence of BDMMs with molecular-level measures and rela-
tions, such as genetic overlap and the interactome-based association score for a depression-
related subset of diseases. Focusing on depression we identified a direct multimorbid neigh-
bourhood and confirmed that direct comorbidities correspond to direct relationships in the
molecular interactome.
Results
We used a subsample of 117,392 subjects from the large-scale cohort of the UK Biobank
resource (http://www.ukbiobank.ac.uk/) in which the presence or absence of lifetime depres-
sion had been established. In the analysis we used 247 diseases with sex and age information,
for the construction of this dataset DUKB, see Materials and methods. At the diseasome level,
we computed and cross-compared pairwise comorbidity measures and measures of direct and
indirect comorbidity relations using a Bayesian systems-based approach. Focusing on depres-
sion, we calculated co-occurence based measures for comorbidities of depression using the lit-
erature and also logistic regression based measures for depression comorbidities using the
UKB data set DUKB. For a depression related subset of diseases, we also evaluated the corre-
spondence of the disease-disease relations with molecular-level measures, including genetic
overlap and the interactome-based association score. Fig 1 shows the outline of the applied
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Fig 1. Workflow of the evaluation. The analysed databases and applied methodologies. Solid lines show the route of the
data whereas dotted lines represent expert validation.
https://doi.org/10.1371/journal.pcbi.1005487.g001
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approaches and their main parameters. In the paper we use interchangeably disease, disorder
and morbidity.
To explore direct and indirect comorbidities, we used Bayesian networks (BN) in the Bayes-
ian model averaging framework [20, 21, 23–25, 42, 43]. In the resulting BDMM an undirected
edge denotes a pairwise ‘co=morbidity’ relation, which corresponds to the presence of an edge
in any orientation between the respective morbidities in the underlying BN. Thus a co=mor-
bidity relation represents direct, unmediated dependence between two disorders, which can-
not be blocked by other diseases (note that this undirected skeleton of a BN does not have the
d-separation based semantics and interpretability as dependency or independency map [43]).
An indirect comorbidity denotes a relationship without direct connection where one or more
diseases directly connect or confound the two disorders (see S1 Appendix) [13]. To quantita-
tively characterize the plausibility of direct and indirect comorbidity relations in this systems-
based approach, we used their respective a posteriori probabilities from Bayesian model aver-
aging. Fig 2 illustrates differences between pairwise and systems-based approaches to explore
multimorbidities on a restricted subset of diseases.
Finally, we also performed multiple analysis with depression as a target: we used text-min-
ing of relevant PubMed abstracts and PMC articles to summarize the known comorbid disor-
ders of depression based on co-occurrence measures, which were compared to data-based
measures, and we also investigated the effect of onset time of depression on the BDMMs
approach.
Comorbidities in the diseasome: Direct or indirect?
To explore the direct and indirect status of comorbidities in the diseasome and to investigate
the effect of filtering disease-mediated, indirect comorbidity relations by BDMMs, we com-
puted multiple pairwise measures. The prevailing non-systems based approaches usually use a
pairwise measure such as odds ratio (OR), Pearson’s correlation coefficient (F) or logistic
regression to determine the epidemiologic relationship of disorders [2, 3]. We computed these
most often used statistical descriptors of comorbidity for all the investigated diseases (see S2
Dataset for all computed pairwise measures for all possible disease pairs). We also computed
BDMMs and cross-compared with the prevailing pairwise approaches [3, 11, 12, 18]. The Fig 3
illustrates the sparsity of the direct (systems-based) map compared to a non-systems based net-
work over the diseasome. The BDMM approach resulted in 320 direct connections (BDMM
edge posterior > 0.95) whereas applying the χ2 independence test 1714 disorder-disorder rela-
tions have significant p-values with a threshold of 0.05 after Bonferroni correction.
We also investigated the sufficiency of the sample size on different approaches. Fig 4 shows
characteristics of the most significant results in each approaches. We transformed the different
scores to the [0, 1] interval to make them comparable (see Materials and methods). Descriptors
and statistics are available on the web (Co=MorNet: bioinformatics.mit.bme.hu/UKBNet-
works), also as an interactive tool to visualise networks of direct and mediated connections of
selected diseases.
The examination of the filtering capacity of the BDMM approach confirms that the BDMM
edge posteriors strongly differentiate the direct connections from the mediated ones, e.g.
there are only a few disease pairs which have a BDMM edge posterior between 0.05 and 0.95
(Fig 5). For the definition of BDMM edge and BDMM (structural) association relations see
Table S1 in S1 Appendix. On Fig 5, we mark the direct comorbid connections with high
BDMM edge posteriors (> 0.95) in red, showing that all of them have significant Bonferroni-
corrected χ2 p-values. Additionally, focusing on a subset of relations with BDMM edge poste-
rior less than 0.95, we examined the BDMM association posteriors versus the parametric
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Fig 2. A matrix, tree and network view of comorbid relations. Sparsity and correspondence of pairwise
associative measure of comorbidity and co=morbidity posteriors of the Bayesian direct multimorbidity maps
(BDMM) using three subsets (clusters) of disorders, namely metabolic syndromes (red), diseases of the
nervous system (blue) and mental and behavioural disorders (green), reported in the UK Biobank dataset.
Top figure a. shows the p-values of the comorbidity associations by χ2 test in purple as pairwise statistical
associations, while the posterior probabilities of co=morbidities derived from the BDMM are in gold below the
Bayesian filtering of the diseasome: Comorbidities of depression
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association (see Fig 6). It confirms that almost all such strongly significant parametric associa-
tion has high BDMM association posterior. Note, that relations with high BDMM edge poste-
rior have high BDMM association posteriors as well. Furthermore, Fig 6 also illustrates that
BDMM association posterior indicates many more structurally distant -presumably parametri-
cally weaker- associations which cannot be inferred by parametric association tests such as
Bonferroni-corrected χ2 p-values.
To evaluate the genetic relevance of direct versus indirect comorbidity relations, we
extended the epidemiological-level analysis with molecular-level approaches using a genetic
overlap [3] and the interactome-based separation score [16]. This analysis included depres-
sion, metabolic syndromes and hypertension, see Fig 7, S2 Fig and Table S3 in S1 Appendix.
The genetic overlap measures for comorbidities were computed based on manually
curated databases, using the DisGeNet [44] and NCBI PheGenI [45] (for details, see S1
Appendix, for a related earlier work, see [2]). The interactome-based connectivity/separation
scores for comorbidities were computed by the supplied method and data from Menche
et al. [16] (see S1 Appendix).
gray diagonal. Middle figure b. as intermediate step towards structural dependencies represents the
hierarchical clustering of diseases based on the pairwise associations (χ2 p-values as distances are used by
the Ward method to compute a hierarchical clustering) resulting three main clusters, which follows the
expected disease groups. Bottom figure c. represents the disease networks, where the gold edges show the
sparse co=morbidities in BDMM while the purple dashed lines show indirect links defined by pairwise
methods. We used the following abbreviations for the disease names: ANXIETY: anxiety/panic attacks, CTS:
carpal tunnel syndrome, CFS: chronic fatigue syndrome, DIAB EYE: diabetic eye disease, HEADACHES NM:
headaches (not migraine), HEAD INJ: head injury, HIGH CHOL: high cholesterol, BD: mania/bipolar disorder/
manic depression, MS: multiple sclerosis, NERVOUS BREAK: nervous breakdown, ONP: other neurological
problem, PD: Parkinson’s disease, PN: peripheral neuropathy, POLIO: polio/poliomyelitis, PN DEP: post-
natal depression, TGN: trigeminal neuralgia.
https://doi.org/10.1371/journal.pcbi.1005487.g002
Fig 3. Sparsity of Bayesian direct morbidity maps of multimorbidities over the diseasome. Figure A shows the network of disorders based on χ2
independence tests whereas figure B represents the sparser BDMM of the same disorders. The node color denotes the different high level ICD-10
categories of the different disorders. The node size is proportional to the prevalence of the diseases. The two gray nodes with multiple connections are sex
and age.
https://doi.org/10.1371/journal.pcbi.1005487.g003
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Comorbidities and co=morbidities of depression
Beside of the investigation of direct and indirect status of comorbidities and the cross-compari-
son of pairwise and BDMM measures, we performed a more detailed medical evaluation of
BDMMs on psychiatric and metabolic disorders, especially on depression and its comorbidities.
Comorbidities of depression based on the scientific literature. We explored the rela-
tions between the set of 426 potential comorbid disorders of depression using shallow text-
Fig 4. The top 5000 connections based on different measures. The BDMM edge posteriors (purple) together with the transformed connection values
(odds ratios: red, risk ratios: blue and χ2 p-values: green). Dashed lines show the cut-off thresholds for the different measures. The given values show the
original OR, RR and χ2 p-values.
https://doi.org/10.1371/journal.pcbi.1005487.g004
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mining methods with 2 different corpora: relevant PubMed abstracts (http://www.ncbi.nlm.
nih.gov/pubmed) and PMC articles(http://www.ncbi.nlm.nih.gov/pmc/). The co-occurring
disease pairs with depression, defined by MeSH terms for major depressive disorder (see
Materials and methods), are listed in S1 Dataset. As expected, the well-known psychiatric
Fig 5. The scatterplot of BDMM posteriors together with transformed Bonferroni-corrected χ2 p-values. The different colors show the connections
which are significant by both methods (red), significant only based on parametric association (green) and not significant (blue). For the BDMM we used a
threshold of 0.95 whereas for the χ2 test a 0.05 threshold after Bonferroni-correction was applied. The density plots are scaled to 1 separately.
https://doi.org/10.1371/journal.pcbi.1005487.g005
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comorbidities of depression, such as bipolar disorder, schizophrenia and anxiety disorders
showed the highest rank in both corpora. Regarding metabolic disorders, diabetes mellitus
ranked highest, followed by obesity. The top ranks of somatic comorbid disorders included
neurodegenerative disorders, dementia, fibromyalgia, chronic fatigue, Parkinson’s disease,
Fig 6. The BDMM structural association and the transformed χ2 p-values. Disease-disease connections shown with less than the 0.95 BDMM edge
posterior. Green dots represents the connections significant by the χ2 independence test (p-value<0.05 after Bonferroni correction), whereas blue dots
denotes the remaining connections.
https://doi.org/10.1371/journal.pcbi.1005487.g006
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and migraine (for full list, see S1 Dataset). In addition, cerebral and cardiovascular disorders
(e.g. heart disease, hypertension) ranked high in the list of disorders based on co-occurrence
with depression.
Comorbidities of depression using non-systems based methods. Pairwise methods,
identified anxiety and other psychiatric conditions as the strongest comorbidities in line with
the literature (schizophrenia n = 94 and dementia n = 17 were too infrequent to be included in
this analysis). These disorders were followed by fibromyalgia, and migraine similarly to the
text-mining results. Cardiovascular (e.g. hypertension) and metabolic disorders (e.g. obesity,
high cholesterol, and diabetes) were also identified as comorbid disorders with depression. To
focus on the factors influencing our target disorder depression, we also applied logistic regres-
sion without interactions as a standard epidemiologic tool. S3 Dataset contains the coefficients
and p-values of the significant disorders corresponding the UK Biobank dataset. There were
many similarities with the pairwise χ2 method but whereas obesity and high cholesterol were
associated to depression, diabetes or other cardiovascular disorders were not. This suggests
that logistic regression may exclude mediated comorbidities (e.g. cardiovascular disorders may
seem comorbid with depression because obesity and high cholesterol independently increase
the risk of both depression and cardiovascular disorders). Painful disorders such as osteoar-
thritis, spondylitis, and back problem showed significant influences on depression in the logis-
tic regression analysis, which are also frequently investigated conditions in association with
depression [35, 36].
Fig 7. Subnetworks of pairwise and systems-based relations from both epidemiological and molecular levels. Solid lines show
the systems-based relations: separation scores with negative values in red and BDMM Pr> 0.05 in green (for exact values see Table S3
in S1 Appendix. Note, that all of them except two relations have posteriors above 0.999). Dashed lines represent the pairwise associative
metrics: relative risk with 95% confidence interval excluding 1 in dark blue (for details see S2 Dataset) and genetic overlap with
hypergeometric distribution p-value below 0.05 in light blue.
https://doi.org/10.1371/journal.pcbi.1005487.g007
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Co=morbidities of depression using systems-based multimorbidity maps. BDMM of
depression can be seen in Fig 8, which shows the co=morbidities of depression and the medi-
ated comorbidities, namely which disorders are not directly comorbid with depression but
comorbid through another direct condition.
In line with the scientific literature and recent genetic studies, our results demonstrated
that anxiety related disorders (anxiety, panic attack, stress, nervous breakdown), and postnatal
depression are highly comorbid with depression (with posterior probability Pr = 0.99) suggest-
ing common biological background. We noted that mania/bipolar disorder/manic-depression
was not co=morbid with depression, suggesting distinct pathogenesis, but both were directly
associated with nervous breakdown. Although nervous breakdown is not a psychiatric diagno-
sis, lay people often refer to it when in the face of stressful situation they could not function
properly in everyday life due to excessive anxiety and depressive symptoms; it can be regarded
as an indication of their severity. Similar stable co=morbidities emerged between psychiatric
disorders when reported depression was replaced in the BDMM by a derived depression cate-
gory based on the Mental Health Questionnaire data [46] (see S1 Appendix and S3 Fig). Tak-
ing into account the severity of depression provided further evidence that mania/bipolar
disorder/manic-depression, nervous breakdown and fibromyalgia are co=morbidities with
severe recurrent depression [46], while obesity was co=morbid with recurrent moderate
depression. Note, that anxiety showed strong co=morbidity with all depression subcategories
(see S1 Appendix and S4 Fig).
Effect of onset time on co=morbidities of depression. To explore the effect of onset
time, we applied the same methodology on a filtered dataset, which excluded instances of dis-
eases that occurred after the onset of depression. Anxiety related disorders and postnatal
depression remained highly comorbid with depression (with posterior probability Pr = 0.99).
Fig 8. The Bayesian direct morbidity map around depression containing the neighbors of depression at
maximum distance of two. The thickness of lines denote the strength of the link for being a member of the
network above the cut-off threshold of posterior probability Pr = 0.05. Sex and age are not shown in the figure as
these nodes would bring along many nodes which are related to depression only through these. Colors indicate
higher level ICD-10 categories.
https://doi.org/10.1371/journal.pcbi.1005487.g008
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Obesity in the full dataset showed a firm (Pr = 0.99) comorbidity with depression regardless of
which depression definition was used (Fig 9 and S3 Fig). Although the time of onset of obesity
is unknown, we retained it as a variable preceding depression, and found similar posteriors in
both models suggesting its direct relevance for and possibly biological overlap with depression.
Interestingly, both high cholesterol and hypertension were indirectly associated with depres-
sion in the full analysis, but showed strong direct comorbidity with depression when occurring
before depression suggesting biological overlap in a subset of patients, although the effect of
environmental factors, such as lifestyle, diet or medication may further increase the risk of
depression in this subpopulation. Regarding diabetes and type 2 diabetes our results showed
that these are not co=morbid disorders with depression but more likely obesity, high choles-
terol, hypertension mediate their high co-occurrence with depression (Fig 9).
Another interesting cluster of comorbid disorders are irritable bowel syndrome (IBS), fibro-
myalgia (FM), chronic fatigue syndrome (CFS) and migraine; all of them showed strong link
with depression based on the text-mining data (S1 Dataset). The BDMM showed that they are
strongly co=morbid with depression in the full analysis but when the onset is before depression
these strong relationships were absent. (S5 Fig). The high posteriors in the full analysis, and
their sharp decrease in the restricted analysis may indicate that these disorders are heteroge-
neous themselves: in some subgroups of disorder the symptoms are part of the depression phe-
notype with high biological overlap but other subgroups maybe independent of depression or
adversities that non-specifically predispose to depression. Similar patterns emerged for insom-
nia, gastro-oesophageal reflux (gord) / gastric reflux, prolapsed disc/slipped disc, and gastritis/
gastric erosions suggesting that in some circumstances they are directly related to depression
but in others they are independent of depression (see web tool, Co=MorNet:bioinformatics.mit.
bme.hu/UKBNetworks). When we changed the depression definition to the one defined by low
mood and anhedonia, ignoring somatic symptoms [46], only chronic fatigue and fibromyalgia
showed co=morbidity with depression, especially with severe depression, suggesting that IBS,
migraine, and other above mentioned somatic disorders may have specific relevance for depres-
sion dominated by somatic symptoms (for further detail see S3 and S4 Figs and S1 Appendix).
Discussion
Large-scale cohort studies collecting life style, environmental, physiological, clinical and
molecular level data, provide unprecedented opportunity for understanding health, pre-
Fig 9. BDMM onset time dependence. BDMM of depression and metabolic disorders and hypertension. a: demonstrates co=morbidities with onset time
prior to depression, while b. showing the BDMM computed on the full data regardless of onset time.
https://doi.org/10.1371/journal.pcbi.1005487.g009
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disease states, multimorbid conditions and progressions, especially to use epidemilogical level
information to complement molecular level discoveries [2, 3, 8–13, 47]. However, the hypothe-
sis-free, omic level use of comorbidites is hindered by multiple factors, such as by errors and
biases in disease coding and collection of clinical information and by confounders like thera-
pies, drug consumption or paradoxically the shared genetic factors themselves. A further
imminent challenge is the presence of disease-mediated or disease-confounded comorbidity
relations, i.e. indirect with respect to the selected diseases. In network science, algebraic solu-
tions were proposed to attenuate indirect relations [19], but these solutions do not take into
account the complex system of probabilistic dependencies between morbidities. We proposed
to use probabilistic graphical models, specifically Bayesian networks to discriminate direct and
indirect relations, because their semantics perfectly captures this aspect [43, 48, 49]. Indeed,
the exact probabilistic treatment of a direct relation with respect to a given set of variables
relies on the practical assumption of stability [48, 50], less demanding than assumptions for a
causal interpretation [51].
Based on this probabilistic foundation of directness (“BDMM edge”), we constructed
BDMMs using a subsample from the UK Biobank cohort to make visible the essential relations
generating the multimorbidity patterns. We investigated BDMMs internally by comparing the
BDMM edge posteriors and the structurally implied associative relations (the BDMM struc-
tural association posteriors), we cross-compared BDMMs with wide-range of pairwise comor-
bidity measures, we compared BDMMs against genetic overlap and interactome-based
comorbidity scores. Additionally, we examined the comorbidity relations of psychiatric and
metabolic disorders, specifically for depression in BDMMs.
Co=morbidities versus structural and parametric associations
First of all, results indicate that the UK Biobank dataset is sufficiently large for the construction
of BDMMs for this variable set, as the BDMM edge posteriors are peaked at 0 and 1 (see upper
part in Fig 5), indeed, with the thresholds 0.05 and 0.95 we can efficiently separate the statisti-
cally significant comorbid relations to direct (co=morbid) and indirect relations. Notably,
BDMMs eliminated more than 80% of comorbidity relations as indirect ones (320 direct con-
nections from 1714 candidate relations). Interestingly, a recent work using a priori disease cat-
egories for restricting comorbidity relations, controlling for confounding with incidence
characteristics and using two independent data sets similarly reported nearly 90% elimination
ratio [12]. Note that all co=morbid connections were also confirmed by standard statistical
methods (the right-lower quadrant is empty in Fig 5), which implies the technical condition
that the distribution of the BDMM posteriors is stable [48–50]. In Fig 6 we further evaluated
the connections with significant Bonferroni-corrected χ2 p-values but below the 0.95 edge pos-
terior threshold. This shows that most of these connections have high BDMM structural asso-
ciation posterior, which suggest that BDMM indeed filtered mediated and confounded
relations. There are 31 connections which have a significant pairwise association score but no
structural association (BDDM structural association posterior < 0.1). These disorder pairs
rarely occur together in patients (mean co-occurrence:8.45, with standard deviation: 4.9, and
quantiles: 5, 7, 10.5 for the 25%, 50% and 75% respectively). In case of the χ2 test we applied
Yates’ continuity correction but for such weak connections even with the large UK Biobank
dataset the BDMM approach was not able to catch that weak dependency structure.
Co=morbidities: Shared genetics and the molecular interactome
Our results demonstrated that the interactome-based score provided similar maps as BDMM
co=morbid diseases, in sharp contrast to the associative genetic overlap scores which followed
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the pattern of the pairwise disease relative risk (see Fig 7, S2 Fig and Table S3 in S1 Appendix).
Note that the interactome-based score and co=morbidity are analogous as both use a systems-
based approach on different levels (molecular and epidemiologic level respectively). For
detailed description of the molecular level methods and results see S1 Appendix and [2, 16].
Psychiatric disorders as co=morbidities with depression
The high comorbidity between mood disorders and anxiety or stress related disorders is well
known, and twin studies suggested that these comorbidities originated mainly from shared
genetic risk factors [52, 53]. Our results showed another expected aspect, namely that this rela-
tionship is independent of the order of the onset of these disorders. This observation is in line
with a longitudinal study which showed that generalised anxiety disorder (GAD) and major
depressive disorder (MDD) are strongly comorbid with an equal probability of GAD or
MDD occurring first or simultaneously suggesting they might not be distinct disorders [54].
Although overlapping genetic risk factors for anxiety and depression have not yet been identi-
fied, common genetic vulnerability has been found for other comorbid psychiatric disorders
[32, 33, 55]. Our BDMM further indicate strong and stable co=morbidity between depression,
anxiety, stress, postnatal depression and nervous breakdown, pointing toward interactome-
level overlaps; this reinforces the need to find potential common biological mechanisms [56].
Multimorbidity pattern of metabolic disorders and hypertension with
depression
Epidemiologic studies repeatedly report high comorbidity between depression and metabolic
disorders [57], depression and diabetes [58], depression and cardiovascular disorders [37],
depression and hypertension [59, 60], and depression and obesity [61, 62]. However, there
have been several contradictory results, and this suggests a more complex relationship. Indeed,
recent GWAS results found no shared genetic risk between these disorders and depression
[55]. Nevertheless, based on the UK Biobank cohort data, obesity was co=morbid with depres-
sion while cardiovascular disorders, hypertension, high cholesterol and diabetes, including
type 2 diabetes were only indirectly related to depression. When we excluded occurrences after
the onset of depression the direct relationship between obesity and depression remained as
expected but entirely new links with high posterior probability emerged suggesting a strong
relationship between the consequences of metabolic syndromes and depression. Studies of the
genetic relationship between obesity and depression suggest that atypical depression, charac-
terised by increase in appetite and weight, is associated with genetic risk factors and polygenic
risk scores of increased BMI and triglycerides, while typical depression, with decreased appe-
tite and weight, show more similarities with other psychiatric disorders [63, 64]. Thus, in line
with our results comorbid obesity and metabolic disorders may identify a specific subtype of
depression with a distinct biological background. Caution is required in inferring shared biol-
ogy for co=morbid disorders given our current lack of knowledge about relevant GxE interac-
tions. Although metabolic disorders are only co=morbid with depression when they precede
it, a variety of non-biological associations of mediators may be at play. We cannot currently
exclude the possibility that lifestyle factors, such as diet, physical activity and stress, or medica-
tion used to treat hypertension, hypercholesterolaemia and obesity may contribute to the later
development of depression [65]. As a specific example, a previous study demonstrated that
current psychological distress amplified the effect of genetic risk of high BMI [66]. Patients
with increased genetic risk to become overweight showed worse physical outcome (higher
BMI), and quite probably more comorbid psychological symptoms, when life stress was pres-
ent. Furthermore, it has been reported that statins, drugs with cholesterol-lowering effect, have
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antidepressant effect in patients with comorbid depression and coronary artery disease while
the same drugs can have pro-depressive effect or no effect on depression when comorbidities
and depression subtypes were not taken into account [67].
Multimorbidity pattern of IBS, FM, CFS and migraine with depression
Migraine [34], IBS [68], FM [69], and CFS [70] are highly comorbid with depression based on
epidemiologic studies. It is therefore puzzling that they involve different etiological mecha-
nisms. In addition, their symptoms often overlap making it difficult to apply diagnostic catego-
ries. We found that these disorders were not relevant when they occurred before depression
but were highly co=morbid in the full analysis. The probable explanation is that in general,
these disorders are related to consequences of depression and only specific subtypes of these
disorders can be expected to have causal relations, e.g. shared biological background with
depression. For example, a genetic risk score analysis demonstrated that migraine with comor-
bid depression was more genetically related to depression than to pure migraine, which sug-
gests that migraine might develop as a consequence of different polygenic backgrounds [71].
Similarly, a large general population cohort study confirmed that FM, CFS and IBS increase
the odds of depression and anxiety but that most patients who suffer from FM, CFS and IBS
have no mood or anxiety disorder [72].
Limitations
One of the main limitations is that all disorders were self-reported, although trained nurses
evaluated and corrected all entries during face-to-face interviews. The second one is that the
applied treatments or medications were not included in the analysis which could highlight
comorbidities due to the side effect of treatments. We will address this problem in follow-up
studies. Note that we only used a subset of the UK Biobank dataset selecting those participants
who filled out the Mental Health Questionnaire and provided online dietary information,
which may introduce confounding through selection bias. However, limiting our study to this
subpopulation enabled us to test different definitions of depression and will allow us to con-
nect this comorbidity network to relevant environmental risk factors.
Conclusion
The use of large-scale health data sets, such as the UK Biobank dataset hold the promise of
complementing and guiding the molecular level research of complex diseases. Adopting an
intermediary approach between statistical association analysis and causal discovery we investi-
gated the use of Bayesian networks in the Bayesian model averaging framework to explore
direct probabilistic relations with respect to a given set of variables, i.e. to eliminate confound-
ers and mediatory effects by a systems-based approach.
We demonstrated the applicability of BDMMs, especially their principled capability of dis-
criminating direct and indirect comorbidities. In summary, PGMs offer maximally sparse
dependency models and utilize the omic nature of the epidemiologic data jointly modelling all
the morbidities; while the Bayesian approach through posteriors provides an explicit represen-
tation for the uncertainties in a dataset. Thus the Bayesian direct morbidity maps provide
sparse, systems-based, omic-wide perspectives.
From a clinical perspective, our results also highlight that the direct and indirect subtypes
of comorbidities support a finer biological interpretation, namely an interactome-based
detailed interpretation using molecular mechanisms corresponding to direct relations,
whereas genetic overlap using associative gene sets may only reflect indirect comorbidities. In
addition, re-running the analysis by including only instances of disorders which preceded
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depression, we delineated comorbid disorders of depression with more refined causal roles
that could specify subgroups of depressed patients with more homogenous background.
The investigation of Bayesian direct morbidity maps also demonstrated, that even large-
scale datasets such as UK Biobank, are still limited for non-ambiguous identification of com-
plex dependency patterns such as multimorbidities [73]. However, the applied Bayesian statis-
tical framework offers an automated, normative solution for the multiple hypothesis testing
problem and the application of probabilistic graphical models in the Bayesian framework sup-
ports the versatile post-processing of the results and their efficient communication and shar-
ing. The results of our research highlight the advantages of Bayesian systems-based modelling,
which could be vital to cope with the growing heterogeneity of new health data sets containing
full personal genetic information with high dimensional data about lifestyle, environmental
factors and sequential decisions on drug therapies [8, 74].
Materials and methods
Databases
In the present study we used the UK Biobank (http://www.ukbiobank.ac.uk/ and [75] cohort
where subjects’ chronic illness history together with onset age were ascertained by trained
nurses during face-to-face interviews and were processed by experts resulting in 525 different
disease categories. The investigated subset in this study consisted of 117,392 participants
(female: 64,320; male: 53,072) who provided the extended Mental Health Questionnaire
(http://biobank.ctsu.ox.ac.uk/crystal/label.cgi?id=100060) and the online diet questionnaire
data together with the extensive baseline dataset. We used the UK Biobank original disease cat-
egories with at least 1‰ prevalence in the selected subset, which resulted in n = 247 diseases
including depression (n = 6040). In addition, we coded obesity in cases where BMI were equal
or greater than 30kg/m2, for further analyses. For statistical analysis, sex was included into the
data set, and age was binned into 3 equal frequency categories with thresholds 60 and 68 years.
Then we applied the different pairwise measures and logistic regression together with Bayesian
systems-based modelling to compare the models computed on these datasets (see below and in
S1 Appendix). To investigate the effect of disease onset, self-reported disease onset data was
used to filter the dataset. 6,040 patients affected by depression, provided onset data whose
comorbid illnesses were eliminated if they occurred after the onset of depression. After
removal of diseases with prevalence less than 1‰ the dataset contained 241 diseases. We
extended the dataset with sex, age and BMI-based obesity. The data were analysed using same
statistical methods as with the non-filtered dataset. To test the stability of comorbid relation-
ships with depression we also used an alternative depression definition instead of self-reported
depressive disorder. Depression and its severity was defined by the Mental Health Question-
naire data [46], for definition see S1 Appendix. These alternative depression categories were
analysed with Bayesian systems-based modelling.
Statistical methods
We applied text-mining and conventional statistical methods to explore comorbid relations,
see S1 Appendix. For these computations we used in-house written R scripts together with the
statistical programs included in the stats package of R [76]. To overcome the limitations of
these conventional methods, we applied a Bayesian network Markov Chain Monte Carlo
(BN-MCMC) method to explore the overall system of dependencies-independencies, visual-
ized as an undirected graph with weighted edges [20, 21, 23–25, 42]. The weighted edges
correspond the a posteriori probabilities (Pr) of direct, nonmediated “co=morbidity” relations,
the weights are in the [0, 1] interval and the higher values show stronger relationship. The
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systems-based approach using Bayesian networks prunes the indirect, mediated connections
between morbidities, thus resulting in a sparse co=morbidity map compared to pairwise asso-
ciation networks (for detailed description of the method and for further types of dependency
relations, see S1 Appendix and Table S1 in S1 Appendix).
Transformations. We transformed odds ratios, risk ratios and χ2 p-values to the [0, 1]





if w2p 6¼ 0







where w2p is the p-value of the χ
2 test and ldðpÞ ¼ max
w2pi>0
ð  log10ðw2piÞÞ. In this paper, we refer to




if 1  OR < 100
1
OROR




















if 1  RR < 100
1
RRRR


















S1 Appendix. Supplementary material. Detailed description of methods.
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S1 Fig. Comparison of different comorbid network approaches.
(TIF)
S2 Fig. Comparison of different molecular- and epidemilogic level statistics.
(TIF)
S3 Fig. Bayesian direct multimorbidity map (BDMM) with the alternative single binary
depression indicator.
(TIF)
S4 Fig. Bayesian direct multimorbidity map (BDMM) using multivariate depression analy-
sis.
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